Your browser doesn't support javascript.
loading
The advantages of switch to subcutaneous bortezomib in the real life.
Mangiacavalli, Silvia; Cocito, Federica; Ferretti, Virginia Valeria; Ganzetti, Maya; Cartia, Claudio Salvatore; Corso, Alessandro.
Afiliación
  • Mangiacavalli S; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Cocito F; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Ferretti VV; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Ganzetti M; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Cartia CS; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
  • Corso A; a Hematology Division, Department of Hematology-Oncology , IRCCS Fondazione Policlinico San Matteo , Pavia , Italy.
Leuk Lymphoma ; 59(6): 1505-1507, 2018 06.
Article en En | MEDLINE | ID: mdl-28980500
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Bortezomib / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Diagnostic_studies Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Bortezomib / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Diagnostic_studies Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article